May 13, 2021 / 09:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Regulus Therapeutics 2021 Financial Results Conference Call. (Operator Instructions) And please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to Cris Calsada. Thank you. Please go ahead.
Crispina Calsada - Regulus Therapeutics Inc. - CFO
Good afternoon, everyone, and thank you for joining us to discuss Regulus Therapeutics first quarter 2021 financial results and corporate highlights. Joining me on today's call is Jay Hagan, President and Chief Executive Officer; and Denis Drygin, Chief Scientific Officer. Jay will provide opening remarks and share progress on our ADPKD program, and I will review the financial results before we open the line for questions.
Before we begin, I would like to remind you that this call will contain forward-looking statements concerning Regulus Therapeutics' future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking
Q1 2021 Regulus Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot